Axcelis to Build New Manufacturing Facility in Pyeongtaek, Korea

BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35 million in its global manufacturing infrastructure through the construction of a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea.

President and CEO Russell Low commented, "This investment reflects Axcelis' continued commitment to strengthening our global high volume manufacturing infrastructure and expanding the capabilities needed to serve our customers around the world. Ion implanters are among the most important tools in front-end semiconductor manufacturing. Building on our established presence in Korea, the new Pyeongtaek facility will enhance our ability to support growing global demand for semiconductors."

The Pyeongtaek site will encompass approximately 200,000 square feet of total gross floor area. The manufacturing center's design will provide a lean production environment that encompasses nearly 50 years of semiconductor capital equipment experience. The Pyeongtaek facility will integrate warehousing, Class 1,000 and Class 10,000 cleanrooms, and a training center, to enable fast and flexible responses to our customers' needs.

As part of this global manufacturing expansion, Robert Mahoney, Executive Vice President, Global Operations, participated in an Investment Declaration Ceremony in Washington, D.C., with representatives from the Ministry of Trade, Industry and Resources (MOTIR) and the Korea Trade-Investment Promotion Agency (KOTRA) last week. A groundbreaking ceremony will follow on October 20, 2026. Production at the new manufacturing facility is scheduled to commence in the second half of 2028.

About Axcelis
Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for nearly 50 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

Safe Harbor Statement:
Statements made in this press release that are not of known historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, including the risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission ("SEC"), including specifically the risk factors described in our most recent Annual Report on Form 10-K and other subsequent filings with the SEC. The Company undertakes no obligation to update the information or statements made in this press release.

CONTACTS:

Investor Relations Contact:
David Ryzhik
Senior Vice President and Interim CFO
Telephone: (978) 787-2352
Email: [email protected]

Press/Media Relations Contacts: 
Maureen Hart
Senior Director, Corporate & Marketing Communications
Telephone: (978) 787-4266
Email: [email protected]

SOURCE Axcelis Technologies, Inc.